Dr. Michael D. Ezekowitz, MD

Dr. Ezekowitz practices at Bryn Mawr Medical Arts Pavilion - HOPD in Bryn Mawr, Pennsylvania.

Dr. Ezekowitz's NPI, 1366413296, was assigned on January 30, 2006. Dr. Ezekowitz graduated from University of Cape Town Faculty of Medicine in 1970. Dr. Ezekowitz holds Pennsylvania license MD070937L.

Dr. Ezekowitz's primary practice is Bryn Mawr Medical Arts Pavilion - HOPD, at 825 Old Lancaster Rd, Bryn Mawr, PA 19010.

Dr. Ezekowitz's primary practice is Bryn Mawr Medical Arts Pavilion - HOPD in Bryn Mawr, Pennsylvania. Dr. Ezekowitz is also affiliated with Bryn Mawr Hospital. Dmand AI also links Dr. Ezekowitz to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ezekowitz practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Ezekowitz's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Ezekowitz is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Ezekowitz's licenses on file in 4 states: Pennsylvania, Connecticut, Maryland and Oklahoma.

Dmand AI lists atrial fibrillation and flutter, chronic hypertension, coronary artery disease, heart blockage, heart failure, heart valve disorders, high cholesterol and intermittent racing heartbeat (PSVT) among the conditions Dr. Ezekowitz treats.

CMS data shows 135 Medicare services from Dr. Ezekowitz across 2 procedure codes in 2024, for 18 Medicare patients. Medicare paid $12,467 for them. Every service was in an office.

CMS counts 18 Medicare patients who saw Dr. Ezekowitz in 2024. The largest group is under 65, with 0 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ezekowitz's median patient age at 75, with 44% women.

In 2024, Dr. Ezekowitz wrote 345 Medicare Part D claims for 23 patients. 79% of them were for generic drugs. CMS names the drug for 226 of them, across 11 drugs with 11 or more claims each, at $66,749 in total drug cost. In 2023, CMS named 191 claims across 8 drugs.

Dr. Ezekowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ezekowitz as offering telehealth.

Dmand AI links 267 papers to Dr. Ezekowitz, published from 2003 to 2024. 2016 was the busiest year, with 19. The most frequent topics are Atrial Fibrillation, Anticoagulants and Stroke. Dr. Ezekowitz has published most often in Circulation. Dr. Ezekowitz's most frequent co-authors are Bernard J. Gersh, MBCHB, Cynthia M. Tracy, MD and Peter R. Kowey, MD.

Dmand AI links Dr. Ezekowitz to 2 clinical trials, 2 of them phase 2 studies. Conditions studied include Atrial Fibrillation and Arrhythmias, Cardiac.

CMS Open Payments shows 214 general payments to Dr. Ezekowitz from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Pfizer Inc. paid the most, $209,953. It also lists 1 research payment totaling $344 in 2018.

Dmand AI lists 1 award for Dr. Ezekowitz.

Dr. Ezekowitz graduated from University of Cape Town Faculty of Medicine in 1970. Dr. Ezekowitz is a member of ACC.

Dr. Ezekowitz is in network with 10 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.